News & Updates

Show Multimedia Only
BMI prognostic of adjuvant chemo potency in breast cancer

BMI prognostic of adjuvant chemo potency in breast cancer

09 Jan 2024 byStephen Padilla

Body mass index (BMI) has some bearing on the efficacy of different adjuvant chemotherapy schedules in patients with early breast cancer, suggest the results of the GIM2 study, which were presented at the recent SABCS 2023. Additionally, dose-dense (DD) chemotherapy appears to be the better treatment strategy regardless of a patient’s BMI.

BMI prognostic of adjuvant chemo potency in breast cancer

09 Jan 2024
Reteplase compares favourably with alteplase for acute ischaemic stroke

Reteplase compares favourably with alteplase for acute ischaemic stroke

05 Jan 2024